AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-93 |
Results: 76-93/93
A RANDOMIZED STUDY WITH THE PINEAL HORMONE MELATONIN VERSUS SUPPORTIVE CARE ALONE IN PATIENTS WITH BRAIN METASTASES DUE TO SOLID NEOPLASMS
Authors: LISSONI P BARNI S ARDIZZOIA A TANCINI G CONTI A MAESTRONI G
Citation: P. Lissoni et al., A RANDOMIZED STUDY WITH THE PINEAL HORMONE MELATONIN VERSUS SUPPORTIVE CARE ALONE IN PATIENTS WITH BRAIN METASTASES DUE TO SOLID NEOPLASMS, Cancer, 73(3), 1994, pp. 699-701
A RANDOMIZED STUDY WITH SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 ALONE VS INTERLEUKIN-2 PLUS THE PINEAL NEUROHORMONE MELATONIN IN ADVANCED SOLIDNEOPLASMS OTHER THAN RENAL-CANCER AND MELANOMA
Authors: LISSONI P BARNI S TANCINI G ARDIZZOIA A RICCI G ALDEGHI R BRIVIO F TISI E ROVELLI F RESCALDANI R QUADRO G MAESTRONI G
Citation: P. Lissoni et al., A RANDOMIZED STUDY WITH SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 ALONE VS INTERLEUKIN-2 PLUS THE PINEAL NEUROHORMONE MELATONIN IN ADVANCED SOLIDNEOPLASMS OTHER THAN RENAL-CANCER AND MELANOMA, British Journal of Cancer, 69(1), 1994, pp. 196-199
INVIVO BIOLOGICAL RESULTS OF THE ASSOCIATION BETWEEN INTERLEUKIN-2 AND INTERLEUKIN-3 IN THE IMMUNOTHERAPY OF CANCER
Authors: LISSONI P BARNI S TISI E ROVELLI F PITTALIS S RESCALDANI R VIGORE L BIONDI A ARDIZZOIA A TANCINI G
Citation: P. Lissoni et al., INVIVO BIOLOGICAL RESULTS OF THE ASSOCIATION BETWEEN INTERLEUKIN-2 AND INTERLEUKIN-3 IN THE IMMUNOTHERAPY OF CANCER, European journal of cancer, 29A(8), 1993, pp. 1127-1132
RESPIRATORY-DISTRESS SYNDROME IN PATIENTS WITH ADVANCED CANCER TREATED WITH PENTOXIFYLLINE - A RANDOMIZED STUDY
Authors: ARDIZZOIA A LISSONI P TANCINI G PAOLOROSSI F CRISPINO S VILLA S BARNI S
Citation: A. Ardizzoia et al., RESPIRATORY-DISTRESS SYNDROME IN PATIENTS WITH ADVANCED CANCER TREATED WITH PENTOXIFYLLINE - A RANDOMIZED STUDY, Supportive care in cancer, 1(6), 1993, pp. 331-333
CANCER-IMMUNOTHERAPY WITH LOW-DOSE INTERLEUKIN-2 SUBCUTANEOUS ADMINISTRATION - POTENTIAL EFFICACY IN MOST SOLID TUMOR HISTOTYPES BY A CONCOMITANT TREATMENT WITH THE PINEAL HORMONE MELATONIN
Authors: LISSONI P BARNI S ARDIZZOIA A OLIVINI G BRIVIO F TISI E TANCINI G CHARACIEJUS D KOTHARI L
Citation: P. Lissoni et al., CANCER-IMMUNOTHERAPY WITH LOW-DOSE INTERLEUKIN-2 SUBCUTANEOUS ADMINISTRATION - POTENTIAL EFFICACY IN MOST SOLID TUMOR HISTOTYPES BY A CONCOMITANT TREATMENT WITH THE PINEAL HORMONE MELATONIN, Journal of biological regulators and homeostatic agents, 7(4), 1993, pp. 121-125
EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ON SOLUBLE INTERLEUKIN-2 RECEPTOR SERUM LEVELS AND THEIR RELATION TO NEOPTERIN AND TUMOR-NECROSIS-FACTOR-ALPHA IN CANCER-PATIENTS
Authors: CRISPINO S LISSONI P ARDIZZOIA A ROVELLI F PEREGO MS GRASSI MG BARNI S PITTALIS S TANCINI G
Citation: S. Crispino et al., EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ON SOLUBLE INTERLEUKIN-2 RECEPTOR SERUM LEVELS AND THEIR RELATION TO NEOPTERIN AND TUMOR-NECROSIS-FACTOR-ALPHA IN CANCER-PATIENTS, Journal of biological regulators and homeostatic agents, 7(3), 1993, pp. 92-94
INHIBITION OF TUMOR-NECROSIS-FACTOR-ALPHA SECRETION BY PENTOXIFYLLINEIN ADVANCED CANCER-PATIENTS WITH ABNORMALLY HIGH BLOOD-LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA
Authors: LISSONI P ARDIZZOIA A PEREGO MS GRASSI MG AROSIO M DAMICO P CAZZANIGA M CRISPINO S TANCINI G BARNI S
Citation: P. Lissoni et al., INHIBITION OF TUMOR-NECROSIS-FACTOR-ALPHA SECRETION BY PENTOXIFYLLINEIN ADVANCED CANCER-PATIENTS WITH ABNORMALLY HIGH BLOOD-LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA, Journal of biological regulators and homeostatic agents, 7(2), 1993, pp. 73-75
CYTOKINE REGULATION OF IRON-METABOLISM - EFFECT OF LOW-DOSE INTERLEUKIN-2 SUBCUTANEOUS THERAPY ON FERRITIN, TRANSFERRIN AND IRON BLOOD-CONCENTRATIONS IN CANCER-PATIENTS
Authors: LISSONI P CAZZANIGA M ARDIZZOIA A ROSSINI F FIORELLI G TANCINI G PITTALIS S BARNI S
Citation: P. Lissoni et al., CYTOKINE REGULATION OF IRON-METABOLISM - EFFECT OF LOW-DOSE INTERLEUKIN-2 SUBCUTANEOUS THERAPY ON FERRITIN, TRANSFERRIN AND IRON BLOOD-CONCENTRATIONS IN CANCER-PATIENTS, Journal of biological regulators and homeostatic agents, 7(1), 1993, pp. 31-33
AMPLIFICATION OF EOSINOPHILIA BY MELATONIN DURING THE IMMUNOTHERAPY OF CANCER WITH INTERLEUKIN-2
Authors: LISSONI P ARDIZZOIA A TISI E ROSSINI F BARNI S TANCINI G CONTI A MAESTRONI GJM
Citation: P. Lissoni et al., AMPLIFICATION OF EOSINOPHILIA BY MELATONIN DURING THE IMMUNOTHERAPY OF CANCER WITH INTERLEUKIN-2, Journal of biological regulators and homeostatic agents, 7(1), 1993, pp. 34-36
A RANDOMIZED STUDY OF LOW-DOSE INTERLEUKIN-2 SUBCUTANEOUS IMMUNOTHERAPY VERSUS INTERLEUKIN-2 PLUS INTERFERON-ALPHA AS FIRST LINE THERAPY FOR METASTATIC RENAL-CELL CARCINOMA
Authors: LISSONI P BARNI S ARDIZZOIA A ANDRES M SCARDINO E CARDELLINI P DELLABITTA R TANCINI G
Citation: P. Lissoni et al., A RANDOMIZED STUDY OF LOW-DOSE INTERLEUKIN-2 SUBCUTANEOUS IMMUNOTHERAPY VERSUS INTERLEUKIN-2 PLUS INTERFERON-ALPHA AS FIRST LINE THERAPY FOR METASTATIC RENAL-CELL CARCINOMA, Tumori, 79(6), 1993, pp. 397-400
SUBCUTANEOUS THERAPY WITH LOW-DOSE INTERLEUKIN-2 PLUS THE NEUROHORMONE MELATONIN IN METASTATIC GASTRIC-CANCER PATIENTS WITH LOW PERFORMANCESTATUS
Authors: LISSONI P BRIVIO F ARDIZZOIA A TANCINI G BARNI S
Citation: P. Lissoni et al., SUBCUTANEOUS THERAPY WITH LOW-DOSE INTERLEUKIN-2 PLUS THE NEUROHORMONE MELATONIN IN METASTATIC GASTRIC-CANCER PATIENTS WITH LOW PERFORMANCESTATUS, Tumori, 79(6), 1993, pp. 401-404
IMMUNOTHERAPY WITH LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS INTERFERON-BETA AS A 2ND-LINE THERAPY FOR METASTATIC COLORECTAL-CARCINOMA
Authors: BARNI S LISSONI P ARDIZZOLA A VIGORE L VEZZO R RESCALDANI R TANCINI G
Citation: S. Barni et al., IMMUNOTHERAPY WITH LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS INTERFERON-BETA AS A 2ND-LINE THERAPY FOR METASTATIC COLORECTAL-CARCINOMA, Tumori, 79(5), 1993, pp. 343-346
IMMUNOENDOCRINE THERAPY WITH INTERLEUKIN-2 (IL-2) AND MEDROXYPROGESTERONE ACETATE (MPA) - A RANDOMIZED STUDY WITH OR WITHOUT MPA IN METASTATIC RENAL-CANCER PATIENTS DURING IL-2 MAINTENANCE TREATMENT AFTER RESPONSE OR STABLE DISEASE TO IL-2 SUBCUTANEOUS THERAPY
Authors: LISSONI P BARNI S TANCINI G BRIVIO F CARDELLINI P VAGHI M FOSSATI V FRIGERIO F
Citation: P. Lissoni et al., IMMUNOENDOCRINE THERAPY WITH INTERLEUKIN-2 (IL-2) AND MEDROXYPROGESTERONE ACETATE (MPA) - A RANDOMIZED STUDY WITH OR WITHOUT MPA IN METASTATIC RENAL-CANCER PATIENTS DURING IL-2 MAINTENANCE TREATMENT AFTER RESPONSE OR STABLE DISEASE TO IL-2 SUBCUTANEOUS THERAPY, Tumori, 79(4), 1993, pp. 246-249
RADIOENDOCRINE THERAPY OF BRAIN-TUMORS WITH THE LONG-ACTING OPIOID ANTAGONIST NALTREXONE IN ASSOCIATION WITH RADIOTHERAPY
Authors: LISSONI P MEREGALLI S FOSSATI V BARNI S TANCINI G BARIGOZZI P FRIGERIO F
Citation: P. Lissoni et al., RADIOENDOCRINE THERAPY OF BRAIN-TUMORS WITH THE LONG-ACTING OPIOID ANTAGONIST NALTREXONE IN ASSOCIATION WITH RADIOTHERAPY, Tumori, 79(3), 1993, pp. 198-201
PREVENTION BY L-CARNITINE OF INTERLEUKIN-2-RELATED CARDIAC TOXICITY DURING CANCER-IMMUNOTHERAPY
Authors: LISSONI P GALLI MA TANCINI G BARNI S
Citation: P. Lissoni et al., PREVENTION BY L-CARNITINE OF INTERLEUKIN-2-RELATED CARDIAC TOXICITY DURING CANCER-IMMUNOTHERAPY, Tumori, 79(3), 1993, pp. 202-204
A WEEKLY SCHEDULE OF EPIRUBICIN IN PRETREATED ADVANCED BREAST-CANCER
Authors: BARNI S ARCHILI C LISSONI P PAOLOROSSI F CRISPINO S TANCINI G
Citation: S. Barni et al., A WEEKLY SCHEDULE OF EPIRUBICIN IN PRETREATED ADVANCED BREAST-CANCER, Tumori, 79(1), 1993, pp. 45-48
A STUDY OF THE MECHANISMS INVOLVED IN THE IMMUNOSTIMULATORY ACTION OFTHE PINEAL HORMONE IN CANCER-PATIENTS
Authors: LISSONI P BARNI S TANCINI G ROVELLI F ARDIZZOIA A CONTI A MAESTRONI GJM
Citation: P. Lissoni et al., A STUDY OF THE MECHANISMS INVOLVED IN THE IMMUNOSTIMULATORY ACTION OFTHE PINEAL HORMONE IN CANCER-PATIENTS, Oncology, 50(6), 1993, pp. 399-402
IMMUNOTHERAPY WITH SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 AND THE PINEALINDOLE MELATONIN AS A NEW EFFECTIVE THERAPY IN ADVANCED CANCERS OF THE DIGESTIVE-TRACT
Authors: LISSONI P BARNI S TANCINI G ARDIZZOIA A ROVELLI F CAZZANIGA M BRIVIO F PIPERNO A ALDEGHI R FOSSATI D CHARACIEJUS D KOTHARI L CONTI A MAESTRONI GJM
Citation: P. Lissoni et al., IMMUNOTHERAPY WITH SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 AND THE PINEALINDOLE MELATONIN AS A NEW EFFECTIVE THERAPY IN ADVANCED CANCERS OF THE DIGESTIVE-TRACT, British Journal of Cancer, 67(6), 1993, pp. 1404-1407
Risultati: 1-25 | 26-50 | 51-75 | 76-93 |